nach oben

11.03.2024 | Review

Type I Interferon Signalling and Ischemic Stroke: Mechanisms and Therapeutic Potentials

verfasst von: Pan Cui, Bo Song, Zongping Xia, Yuming Xu

Erschienen in: Translational Stroke Research

Einloggen, um Zugang zu erhalten

Abstract

Type I interferon (IFN-I) signalling is intricately involved in the pathogenesis of multiple infectious diseases, autoimmune diseases, and neurological diseases. Acute ischemic stroke provokes overactivation of IFN-I signalling within the injured brain, particularly in microglia. Following cerebral ischemia, damage-associated molecular patterns (DAMPs) released from injured neural cells elicit marked proinflammatory episodes within minutes. Among these, self-nucleic acids, including nuclear DNA and mitochondrial DNA (mtDNA), have been recognized as a critical alarm signal to fan the flames of neuroinflammation, predominantly via inducing IFN-I signalling activation in microglia. The concept of interferon-responsive microglia (IRM), marked by upregulation of a plethora of IFN-stimulated genes, has been emergingly elucidated in ischemic mouse brains, particularly in aged ones. Among the pattern recognition receptors responsible for IFN-I induction, cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) plays integral roles in potentiating microglia-driven neuroinflammation and secondary brain injury after cerebral ischemia. Here, we aim to provide an up-to-date review on the multifaceted roles of IFN-I signalling, the detailed molecular and cellular mechanisms leading to and resulting from aberrant IFN-I signalling activation after cerebral ischemia, and the therapeutic potentials. A thorough exploration of these above points will inform our quest for IFN-based therapies as effective immunomodulatory therapeutics to complement the limited repertoire of thrombolytic agents, thereby facilitating the translation from bench to bedside.

Johnson CO, Nguyen M, Roth GA, Nichols E, Alam T, Abate D, et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:439–58.CrossRef

Cui P, McCullough LD, Hao J. Brain to periphery in acute ischemic stroke: mechanisms and clinical significance. Front Neuroendocrinol. 2021;63:100932.PubMedPubMedCentralCrossRef

Stanzione R, Forte M, Cotugno M, Bianchi F, Marchitti S, Rubattu S. Role of DAMPs and of leukocytes infiltration in ischemic stroke: insights from animal models and translation to the human disease. Cell Mol Neurobiol. 2022;42:545–56.PubMedCrossRef

Singh V, Roth S, Veltkamp R, Liesz A. HMGB1 as a key mediator of immune mechanisms in ischemic stroke. Antioxid Redox Signal. 2016;24:635–51.PubMedCrossRef

Kim SW, Davaanyam D, Seol SI, Lee HK, Lee H, Lee JK. Adenosine triphosphate accumulated following cerebral ischemia induces neutrophil extracellular trap formation. Int J Mol Sci. 2020;21:7688.

Li Q, Cao Y, Dang C, Han B, Han R, Ma H, et al. Inhibition of double-strand DNA-sensing cGAS ameliorates brain injury after ischemic stroke. EMBO Mol Med. 2020;12:e11002.PubMedPubMedCentralCrossRef

Kong L, Li W, Chang E, Wang W, Shen N, Xu X, et al. mtDNA-STING axis mediates microglial polarization via IRF3/NF-κB signaling after ischemic stroke. Front Immunol. 2022;13:860977.PubMedPubMedCentralCrossRef

Jiang GL, Yang XL, Zhou HJ, Long J, Liu B, Zhang LM, et al. cGAS knockdown promotes microglial M2 polarization to alleviate neuroinflammation by inhibiting cGAS-STING signaling pathway in cerebral ischemic stroke. Brain Res Bull. 2021;171:183–95.PubMedCrossRef

Fischer S, Nasyrov E, Brosien M, Preissner KT, Marti HH, Kunze R. Self-extracellular RNA promotes pro-inflammatory response of astrocytes to exogenous and endogenous danger signals. J Neuroinflammation. 2021;18:252.PubMedPubMedCentralCrossRef

10.

Fischer S, Gerriets T, Wessels C, Walberer M, Kostin S, Stolz E, et al. Extracellular RNA mediates endothelial-cell permeability via vascular endothelial growth factor. Blood. 2007;110:2457–65.PubMedCrossRef

11.

Sharp FR, Zhan X, Liu DZ. Heat shock proteins in the brain: role of Hsp70, Hsp 27, and HO-1 (Hsp32) and their therapeutic potential. Transl Stroke Res. 2013;4:685–92.PubMedCrossRef

12.

Tan PH, Ji J, Hsing CH, Tan R, Ji RR. Emerging roles of type-I interferons in neuroinflammation, Neurological Diseases, and Long-Haul COVID. Int J Mol Sci. 2022;23:14394.

13.

McDonough A, Lee RV, Noor S, Lee C, Le T, Iorga M, et al. Ischemia/reperfusion induces interferon-stimulated gene expression in microglia. J Neurosci. 2017;37:8292–308.PubMedPubMedCentralCrossRef

14.

Arbaizar-Rovirosa M, Pedragosa J, Lozano JJ, Casal C, Pol A, Gallizioli M, et al. Aged lipid-laden microglia display impaired responses to stroke. EMBO Mol Med. 2023;15:e17175.PubMedCrossRef

15.

Androvic P, Kirdajova D, Tureckova J, Zucha D, Rohlova E, Abaffy P, et al. Decoding the transcriptional response to ischemic stroke in young and aged mouse brain. Cell Rep. 2020;31:107777.PubMedCrossRef

16.

Zhang Y, Guo Y, Li R, Huang T, Li Y, Xie W, et al. Novel CH25H(+) and OASL(+) microglia subclusters play distinct roles in cerebral ischemic stroke. J Neuroinflammation. 2023;20:115.PubMedPubMedCentralCrossRef

17.

Field R, Campion S, Warren C, Murray C, Cunningham C. Systemic challenge with the TLR3 agonist poly I: C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav Immun. 2010;24:996–1007.PubMedPubMedCentralCrossRef

18.

Roy ER, Chiu G, Li S, Propson NE, Kanchi R, Wang B, et al. Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid β plaques. Immunity. 2022;55:879-894.e6.PubMedPubMedCentralCrossRef

19.

Roy ER, Wang B, Wan YW, Chiu G, Cole A, Yin Z, et al. Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Invest. 2020;130:1912–30.PubMedPubMedCentralCrossRef

20.

C. Sala Frigerio, L. Wolfs, N. Fattorelli, N. Thrupp, I. Voytyuk, I. Schmidt, et al. The major risk factors for Alzheimer’s disease: age, sex, and genes modulate the microglia response to Aβ plaques, Cell Reports. 2019;27:1293–1306.e6.

21.

Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model. J Exp Med. 2020;217:e20200785.

22.

Udeochu JC, Amin S, Huang Y, Fan L, Torres ERS, Carling GK, et al. Tau activation of microglial cGAS-IFN reduces MEF2C-mediated cognitive resilience. Nat Neurosci. 2023;26:737–50.PubMedPubMedCentralCrossRef

23.

Olah M, Menon V, Habib N, Taga MF, Ma Y, Yung CJ, et al. Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease. Nat Commun. 2020;11:6129.ADSPubMedPubMedCentralCrossRef

24.

Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A, et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50:253-271.e6.PubMedCrossRef

25.

Dong Y, D’Mello C, Pinsky W, Lozinski BM, Kaushik DK, Ghorbani S, et al. Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurodegeneration and are neutralized by microglia. Nat Neurosci. 2021;24:489–503.PubMedCrossRef

26.

Kaya T, Mattugini N, Liu L, Ji H, Cantuti-Castelvetri L, Wu J, et al. CD8(+) T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging. Nat Neurosci. 2022;25:1446–57.PubMedPubMedCentralCrossRef

27.

Zheng K, Lin L, Jiang W, Chen L, Zhang X, Zhang Q, et al. Single-cell RNA-seq reveals the transcriptional landscape in ischemic stroke. J Cereb Blood Flow Metab. 2022;42:56–73.PubMedCrossRef

28.

McNab F, Mayer-Barber K, Sher A, Wack A, O’Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15:87–103.PubMedPubMedCentralCrossRef

29.

Shen Q, Li J, Zhang Z, Guo S, Wang Q, An X, et al. COVID-19: systemic pathology and its implications for therapy. Int J Biol Sci. 2022;18:386–408.PubMedPubMedCentralCrossRef

30.

Suzzi S, Tsitsou-Kampeli A, Schwartz M. The type I interferon antiviral response in the choroid plexus and the cognitive risk in COVID-19. Nat Immunol. 2023;24:220–4.PubMedCrossRef

31.

Cai C, Tang YD, Xu G, Zheng C. The crosstalk between viral RNA- and DNA-sensing mechanisms. Cell Mol Life Sci. 2021;78:7427–34.PubMedPubMedCentralCrossRef

32.

Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21:548–69.PubMedPubMedCentralCrossRef

33.

Lukhele S, Boukhaled GM, Brooks DG. Type I interferon signaling, regulation and gene stimulation in chronic virus infection. Semin Immunol. 2019;43:101277.PubMedPubMedCentralCrossRef

34.

Zhang M, Downes CE, Wong CHY, Brody KM, Guio-Agulair PL, Gould J, et al. Type-I interferon signalling through IFNAR1 plays a deleterious role in the outcome after stroke. Neurochem Int. 2017;108:472–80.PubMedCrossRef

35.

Costello DA, Lynch MA. Toll-like receptor 3 activation modulates hippocampal network excitability, via glial production of interferon-β. Hippocampus. 2013;23:696–707.PubMedCrossRef

36.

Cox DJ, Field RH, Williams DG, Baran M, Bowie AG, Cunningham C, et al. DNA sensors are expressed in astrocytes and microglia in vitro and are upregulated during gliosis in neurodegenerative disease. Glia. 2015;63:812–25.PubMedPubMedCentralCrossRef

37.

Furr SR, Chauhan VS, Moerdyk-Schauwecker MJ, Marriott I. A role for DNA-dependent activator of interferon regulatory factor in the recognition of herpes simplex virus type 1 by glial cells. J Neuroinflammation. 2011;8:99.PubMedPubMedCentralCrossRef

38.

Furr SR, Chauhan VS, Sterka D Jr, Grdzelishvili V, Marriott I. Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus. J Neurovirol. 2008;14:503–13.PubMedCrossRef

39.

Kallfass C, Ackerman A, Lienenklaus S, Weiss S, Heimrich B, Staeheli P. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J Virol. 2012;86:11223–30.PubMedPubMedCentralCrossRef

40.

G.M. Welch, C.A. Boix, E. Schmauch, J. Davila-Velderrain, M.B. Victor, V. Dileep, et al. Neurons burdened by DNA double-strand breaks incite microglia activation through antiviral-like signaling in neurodegeneration. Sci Adv. 2022;8:eabo4662.

41.

Liao Y, Cheng J, Kong X, Li S, Li X, Zhang M, et al. HDAC3 inhibition ameliorates ischemia/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway. Theranostics. 2020;10:9644–62.PubMedPubMedCentralCrossRef

42.

Kang L, Yu H, Yang X, Zhu Y, Bai X, Wang R, et al. Neutrophil extracellular traps released by neutrophils impair revascularization and vascular remodeling after stroke. Nat Commun. 2020;11:2488.ADSPubMedPubMedCentralCrossRef

43.

Wang R, Zhu Y, Liu Z, Chang L, Bai X, Kang L, et al. Neutrophil extracellular traps promote tPA-induced brain hemorrhage via cGAS in mice with stroke. Blood. 2021;138:91–103.PubMedPubMedCentralCrossRef

44.

Marsh B, Stevens SL, Packard AE, Gopalan B, Hunter B, Leung PY, et al. Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J Neurosci. 2009;29:9839–49.PubMedPubMedCentralCrossRef

45.

Cui G, Ye X, Zuo T, Zhao H, Zhao Q, Chen W, et al. Chloroquine pretreatment inhibits toll-like receptor 3 signaling after stroke. Neurosci Lett. 2013;548:101–4.PubMedCrossRef

46.

Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, Lin XJ, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature. 2018;560:198–203.ADSPubMedPubMedCentralCrossRef

47.

Peng J, Wang H, Gong Z, Li X, He L, Shen Q, et al. Idebenone attenuates cerebral inflammatory injury in ischemia and reperfusion via dampening NLRP3 inflammasome activity. Mol Immunol. 2020;123:74–87.PubMedCrossRef

48.

Han W, Pu H, Li S, Liu Y, Zhao Y, Xu M, et al. Targeted ablation of signal transducer and activator of transduction 1 alleviates inflammation by microglia/macrophages and promotes long-term recovery after ischemic stroke. J Neuroinflammation. 2023;20:178.PubMedPubMedCentralCrossRef

49.

Gallizioli M, Miró-Mur F, Otxoa-de-Amezaga A, Cugota R, Salas-Perdomo A, Justicia C, et al. Dendritic cells and microglia have non-redundant functions in the inflamed brain with protective effects of type 1 cDCs. Cell Rep. 2020;33:108291.PubMedPubMedCentralCrossRef

50.

Harmon E, Doan A, Bautista-Garrido J, Jung JE, Marrelli SP, Kim GS. Increased expression of interferon-induced transmembrane 3 (IFITM3) in stroke and other inflammatory conditions in the brain. Int J Mol Sci. 2022;23:8885.

51.

Cui P, Lu W, Wang J, Wang F, Zhang X, Hou X, et al. Microglia/macrophages require vitamin D signaling to restrain neuroinflammation and brain injury in a murine ischemic stroke model. J Neuroinflammation. 2023;20:63.PubMedPubMedCentralCrossRef

52.

Baruch K, Deczkowska A, David E, Castellano JM, Miller O, Kertser A, et al. Aging-induced type I interferon response at the choroid plexus negatively affects brain function. Science. 2014;346:89–93.ADSPubMedPubMedCentralCrossRef

53.

Deczkowska A, Matcovitch-Natan O, Tsitsou-Kampeli A, Ben-Hamo S, Dvir-Szternfeld R, Spinrad A, et al. Mef2C restrains microglial inflammatory response and is lost in brain ageing in an IFN-I-dependent manner. Nat Commun. 2017;8:717.ADSPubMedPubMedCentralCrossRef

54.

Glück S, Guey B, Gulen MF, Wolter K, Kang TW, Schmacke NA, et al. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat Cell Biol. 2017;19:1061–70.PubMedPubMedCentralCrossRef

55.

Victorelli S, Salmonowicz H, Chapman J, Martini H, Vizioli MG, Riley JS, et al. Apoptotic stress causes mtDNA release during senescence and drives the SASP. Nature. 2023;622:627–36.ADSPubMedPubMedCentralCrossRef

56.

Goldmann T, Blank T, Prinz M. Fine-tuning of type I IFN-signaling in microglia–implications for homeostasis CNS autoimmunity and interferonopathies. Curr Opin Neurobiol. 2016;36:38–42.PubMedCrossRef

57.

Hosseini S, Michaelsen-Preusse K, Grigoryan G, Chhatbar C, Kalinke U, Korte M. Type I interferon receptor signaling in astrocytes regulates hippocampal synaptic plasticity and cognitive function of the healthy CNS. Cell Rep. 2020;31:107666.PubMedCrossRef

58.

Derfuss T, Mehling M, Papadopoulou A, Bar-Or A, Cohen JA, Kappos L. Advances in oral immunomodulating therapies in relapsing multiple sclerosis. Lancet Neurol. 2020;19:336–47.PubMedCrossRef

59.

Liu H, Xin L, Chan BP, Teoh R, Tang BL, Tan YH. Interferon-beta administration confers a beneficial outcome in a rabbit model of thromboembolic cerebral ischemia. Neurosci Lett. 2002;327:146–8.PubMedCrossRef

60.

Veldhuis WB, Derksen JW, Floris S, Van Der Meide PH, De Vries HE, Schepers J, et al. Interferon-beta blocks infiltration of inflammatory cells and reduces infarct volume after ischemic stroke in the rat. J Cereb Blood Flow Metab. 2003;23:1029–39.PubMedCrossRef

61.

Kuo PC, Scofield BA, Yu IC, Chang FL, Ganea D, Yen JH. Interferon-β modulates inflammatory response in cerebral ischemia. J Am Heart Assoc. 2016;5:e002610.

62.

Kuo PC, Weng WT, Scofield BA, Furnas D, Paraiso HC, Intriago AJ, et al. Interferon-β alleviates delayed tPA-induced adverse effects via modulation of MMP3/9 production in ischemic stroke. Blood Adv. 2020;4:4366–81.PubMedPubMedCentralCrossRef

63.

Kuo PC, Weng WT, Scofield BA, Paraiso HC, Bojrab P, Kimes B, et al. Interferon-β modulates microglial polarization to ameliorate delayed tPA-exacerbated brain injury in ischemic stroke. Front Immunol. 2023;14:1148069.PubMedPubMedCentralCrossRef

64.

Hamner MA, Ye Z, Lee RV, Colman JR, Le T, Gong DC, et al. Ischemic preconditioning in white matter: magnitude and mechanism. J Neurosci. 2015;35:15599–611.PubMedPubMedCentralCrossRef

65.

Stevens SL, Leung PY, Vartanian KB, Gopalan B, Yang T, Simon RP, et al. Multiple preconditioning paradigms converge on interferon regulatory factor-dependent signaling to promote tolerance to ischemic brain injury. J Neurosci. 2011;31:8456–63.PubMedPubMedCentralCrossRef

66.

Maier CM, Yu F, Nishi T, Lathrop SJ, Chan PH. Interferon-beta fails to protect in a model of transient focal stroke. Stroke. 2006;37:1116–9.PubMedCrossRef

67.

Inácio AR, Liu Y, Clausen BH, Svensson M, Kucharz K, Yang Y, et al. Endogenous IFN-β signaling exerts anti-inflammatory actions in experimentally induced focal cerebral ischemia. J Neuroinflammation. 2015;12:211.PubMedPubMedCentralCrossRef

68.

Li L, Qin JJ, Guo S, Zhang P, Gong J, Zhang XJ, et al. Attenuation of cerebral ischemic injury in interferon regulatory factor 3-deficient rat. J Neurochem. 2016;136:871–83.PubMedCrossRef

69.

Gullotta GS, De Feo D, Friebel E, Semerano A, Scotti GM, Bergamaschi A, et al. Age-induced alterations of granulopoiesis generate atypical neutrophils that aggravate stroke pathology. Nat Immunol. 2023;24:925–40.PubMedCrossRef

70.

Nakka VP, Lang BT, Lenschow DJ, Zhang DE, Dempsey RJ, Vemuganti R. Increased cerebral protein ISGylation after focal ischemia is neuroprotective. J Cereb Blood Flow Metab. 2011;31:2375–84.PubMedPubMedCentralCrossRef

71.

N. Kundu, A. Kumar, C. Corona, Y. Chen, S. Seth, S.S. Karuppagounder, et al. A STING agonist preconditions against ischaemic stroke via an adaptive antiviral Type 1 interferon response, Brain Commun. 2022;4:fcac133.

Titel: Type I Interferon Signalling and Ischemic Stroke: Mechanisms and Therapeutic Potentials
verfasst von: Pan Cui
Bo Song
Zongping Xia
Yuming Xu
Publikationsdatum: 11.03.2024
Verlag: Springer US
Erschienen in: Translational Stroke Research
Print ISSN: 1868-4483
Elektronische ISSN: 1868-601X
DOI: https://doi.org/10.1007/s12975-024-01236-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen